Peptide therapy

A signal to your body, not a substitute for it

Peptides are short chains of amino acids that your body already uses as messengers. Therapeutic peptides work the same way — they carry an instruction to a system that has slowed down, rather than replacing what that system produces. The distinction matters more than it sounds like it should.

Peptides are prescribed only after a consultation and appropriate lab work with our medical team, and are dispensed through licensed compounding pharmacies.

Natural pulsatile release versus continuous replacement Growth hormone over twenty-four hours. The natural pattern is a series of bursts with the largest occurring during deep sleep. Replacement therapy instead holds a flat, constantly elevated level. deep sleep 6am noon 6pm 12am 6am Growth hormone across 24 hours Natural pulsatile release Continuous replacement Peptide therapy aims to preserve the natural rhythm.

How care works

Prescribed, monitored, and sourced through licensed pharmacies

Peptides are widely sold online by companies that are not permitted to sell them for human use. What we offer is a different thing entirely: a physician-prescribed protocol with lab work behind it.

Consult

A conversation about your goals, symptoms, history, and whether a peptide protocol is a sensible fit for what you're trying to address.

Test

Appropriate lab work before prescribing. For growth hormone secretagogues this matters especially, since untreated thyroid or endocrine issues blunt the response.

Prescribe

Your protocol is dispensed by a licensed compounding pharmacy, with the delivery method chosen to suit the peptide and your preference.

Follow up

We reassess response, adjust dosing, and repeat labs as needed. Peptides are not a prescription you start and never revisit.

The basic idea

Short chains of amino acids, used as messages

Proteins are long chains of amino acids. Peptides are short ones — typically a few dozen at most. Your body manufactures hundreds of them and uses them as signaling molecules: instructions sent from one tissue to another telling it to release a hormone, repair damage, or change a metabolic setting.

Therapeutic peptides borrow that vocabulary. Rather than supplying a finished hormone from outside, most work by delivering a signal your body already recognizes, to a system that has become less responsive or less active with age. The body still does the work, and still controls how much work it does.

Replacing a hormone overrides the system. Signaling it asks the system to resume.

Our primary growth hormone peptide

Sermorelin, and why we prefer it to growth hormone itself

Sermorelin is a synthetic peptide made of the first 29 amino acids of your body's own growth hormone-releasing hormone (GHRH). Those 29 amino acids are the business end of the natural hormone — the shortest fragment that retains full biological activity. Sermorelin is not growth hormone. It is a signal asking your body to produce its own.

It also carries a meaningful regulatory history. Sermorelin was once an FDA-approved prescription medication, marketed as Geref, and it was withdrawn from the market for commercial reasons rather than safety concerns. Because it was a component of an FDA-approved drug, sermorelin remains eligible to be prepared by licensed compounding pharmacies today, which is why we're able to offer it as a physician-prescribed injectable.

  1. It targets the pituitary gland After a small subcutaneous injection, sermorelin travels to the anterior pituitary and binds GHRH receptors on the somatotroph cells there.
  2. The pituitary releases your own growth hormone The signal prompts secretion of growth hormone your body manufactured itself, in the amount your pituitary determines is appropriate.
  3. Release stays pulsatile Your body normally releases growth hormone in rhythmic bursts, the largest during deep sleep. Because sermorelin works upstream through your own pituitary, that natural pattern is preserved rather than replaced by constant artificial elevation. It's why sermorelin is typically injected in the evening — working with your nocturnal rhythm rather than against it.
  4. Growth hormone signals the liver to produce IGF-1 Once released, growth hormone travels to the liver and other tissues and stimulates production of insulin-like growth factor 1. IGF-1 is the primary messenger through which growth hormone carries out much of its work — supporting lean tissue maintenance, cellular repair, and metabolic function.
  5. Your safety brakes stay intact Because sermorelin stimulates rather than replaces, your natural feedback loops remain fully functional. The pituitary can still decline the request.
The growth hormone axis Sermorelin signals the pituitary, which releases growth hormone, which prompts the liver to make IGF-1, which acts on tissues. A feedback loop runs back from the tissues to the pituitary, keeping the body's own regulation intact. Sermorelin first 29 amino acids of GHRH Pituitary gland GHRH receptors on somatotrophs Growth hormone released in natural pulses Liver produces IGF-1 the main downstream messenger Lean tissue and repair plus metabolic function feedback stays intact

The practical takeaway: sermorelin supports the body's own growth hormone axis rather than overriding it. Physiologic pulsatility is preserved, feedback inhibition is preserved, and the pituitary continues doing its job. Patients and providers often prefer this approach precisely because it restores a pattern of secretion that naturally declines with age, rather than imposing supraphysiologic hormone levels from the outside.

Delivery

For select regenerative peptides, we use iontophoresis instead of needles

Iontophoresis is a long-established medical technique, used for decades in physical therapy and dermatology, that applies a gentle, low-level electrical current to the skin. Because like charges repel, the current actively pushes the peptide molecules through the skin barrier rather than waiting for them to diffuse across on their own.

The result is transdermal delivery without an injection. For patients who are needle-averse, or for protocols where a localized application makes more sense than a systemic one, it's a meaningful alternative.

Needle-free

No injection, no sharps disposal, and none of the hesitation that keeps some patients from starting a protocol at all.

Well established

The technique itself is not new. It has been used in physical therapy and dermatology clinics for decades to drive medication through skin.

Applied where needed

For regenerative peptides aimed at a specific area, delivering at the site is often more sensible than treating the whole body.

The three we deliver this way

Regenerative peptides, applied to the tissue rather than injected into it

BPC-157

Body Protection Compound-157

A fifteen-amino-acid sequence derived from a protein found in gastric juice. Studied for tendon, ligament, muscle, nerve, and gut lining repair, and for its effects on new blood vessel formation.

TB-500

Thymosin beta-4 fragment

A synthetic fragment of a naturally occurring protein involved in cell migration and wound repair. Studied for soft tissue healing, tissue flexibility, and inflammation.

KPV

Lysine–proline–valine

A three-amino-acid fragment of alpha-melanocyte-stimulating hormone. Studied primarily for anti-inflammatory activity at skin and mucosal surfaces.

Why we use iontophoresis for these three specifically

This is a deliberate choice rather than a convenience. Each of these peptides is prescribed for repair in a particular area, and each raises different considerations when given by needle than when applied to the surface.

  • The skin barrier stays intact Iontophoresis moves the molecule across the dermis using an electrical gradient. Nothing punctures the skin, so there is no wound, no injection site to care for, and no sharps involved.
  • It is not a sterile injectable preparation Anything injected has to meet sterile compounding standards and carries the risks that go with breaching the skin — injection site reactions, contamination, and the immunogenicity concerns that attach specifically to injected peptides. A transdermal preparation sits in a different, more established category of compounding.
  • Delivery happens where the problem is These peptides are used for localized repair — a tendon, a joint, an area of inflammation. Applying at that site is more logical than circulating the compound through the whole body to reach it.
  • It reflects how we read the regulatory picture The compounding rules governing these substances have been in flux, and the concerns regulators have raised center substantially on injectable routes. Delivering transdermally is the more conservative position, and it is the one we have chosen to take.

An honest word on the evidence. Most of what is known about these three peptides comes from laboratory and animal research rather than large human trials. They are not FDA-approved drugs. We think the mechanisms are compelling and the safety signals to date are reassuring, and we also think you should hear that from us rather than discover it later. Your provider will discuss what is and isn't established before you begin.

What peptides are used for

Three areas where peptide protocols are most often considered

Which peptide is appropriate — and whether one is appropriate at all — depends on your labs, your goals, and what a licensed compounding pharmacy can currently prepare. Your provider will walk you through the specific options at your consultation.

Growth hormone axis support

Peptides that prompt the pituitary to release your own growth hormone, aimed at sleep quality, recovery, body composition, and lean tissue maintenance as natural secretion declines with age.

Tissue repair and recovery

The regenerative peptides described above — BPC-157, TB-500, and KPV — aimed at musculoskeletal healing, connective tissue, and inflammation, and delivered transdermally rather than by injection.

Sexual health

Peptides that act on arousal pathways in the central nervous system rather than on blood flow or hormone levels, making them a different tool from testosterone or vasodilators.

Worth understanding

How compounded peptides are regulated, and why we tell you about it

Most therapeutic peptides are not FDA-approved drugs. They are prepared by licensed compounding pharmacies under a framework that governs which bulk substances may be used — and that framework has been actively changing. Several widely marketed peptides were restricted from compounding in 2023, and a number of those decisions have been under formal review since.

This matters for two reasons. First, it means what a clinic can legitimately prescribe shifts over time, and any practice claiming otherwise is not paying attention. Second, it explains the flood of peptides sold online as "research chemicals, not for human consumption." Those products sit outside the pharmacy system entirely, with no verification of identity, purity, or dose.

We prescribe through licensed compounding pharmacies, and we tell patients plainly where a given compound stands. If something we previously offered is no longer available to dispense, we say so rather than substituting quietly.

Peptide therapies are prescribed only following clinical evaluation and appropriate laboratory testing, and are not appropriate for every patient. Most compounded peptides are not FDA-approved drugs, and the regulatory status of individual compounds under Section 503A of the Federal Food, Drug, and Cosmetic Act is subject to change; availability may differ from what is described here. Sermorelin acetate was previously FDA-approved and withdrawn from the market for commercial reasons. Individual results vary and no outcome can be guaranteed. This page is for educational purposes and is not a substitute for a medical evaluation or for discussing your personal health history with a licensed provider.

Would you like to learn more about the benefits of Peptide Therapy? Click the link below to request a free consultation.

Previous
Previous

Medically Assisted Weight Loss

Next
Next

Women's Sexual Health